India · Delayed Price · Currency is INR Camlin Fine Sciences Earnings Call Transcripts
Fiscal Year 2026
-
Revenue and EBITDA were impacted by global logistics and raw material costs, but discontinued operations and tariff reductions improved profitability. FY 2027 guidance remains strong, with vanillin and blends segments expected to drive growth and margins.
-
Q3 revenue grew 6% year-over-year to INR 572 crore, with blends up 11% and vanillin sales managed for tariff optimization. FY 2027 guidance targets 4,000 tons vanillin, 25% blends growth, and improved margins, while liquidation of European and Chinese subsidiaries aims to halt cash losses.
-
Quarterly revenue grew 8.6% sequentially, led by strong volume recovery in trades and blends, with vanillin sales up 35% but realizations pressured by tariffs. Management reaffirmed full-year sales and volume guidance, with growth supported by field force expansion and a new French acquisition.
-
Q1 FY2026 saw revenue and EBITDA decline due to plant shutdowns and one-time costs, but the blends business continued strong growth. Vanillin production ran at 50% capacity, with tariffs and channel inventory impacting near-term outlook. Gross margins are expected to stabilize at 40%-45%.
Fiscal Year 2025
-
FY2025 revenue rose 15% year-over-year, led by strong blend and vanillin growth, with core EBITDA margin at 12.5%. Vanillin prices and margins are set to benefit from anti-dumping duties in the U.S. and Europe, while discontinued operations' cash burn will reduce sharply.
-
Revenue and margins improved year-over-year, with vanillin and blends segments showing strong growth. Anti-dumping duties are boosting vanillin prices, while rights issue proceeds have strengthened the balance sheet and reduced debt.
-
Revenue rose 6.9% sequentially to INR 422 crore, with gross margin at 48.2% and EBITDA margin at 10.2%. Major impairments in Europe and China were recognized, and a rights issue is planned to address liquidity. Blend and aroma segments are set for strong growth, with double-digit EBITDA margins expected.
-
Q1 FY25 saw stable revenues and improved margins despite global demand weakness and pricing headwinds. Blends business grew strongly, while European operations remained a drag. Management expects double-digit EBITDA margins for FY25, aided by acquisitions and anti-dumping actions.